Suchergebnisse - "antitumor immune response"

PubPharm (301)

51

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response

enthalten in: Frontiers in physiology | 2022

von Wang, Q. | Chai, D. | Sobhani, N. | +4

52

Targets and Strategies for Cancer Immunoprevention

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2022

von Unver, N. | Mohindroo, C.

53

Evaluation of the Antitumor Immune Response Following Photofrin-Based PDT in Combination with the Epigenetic Agent 5-Aza-2'-Deoxycytidine

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2022

von Wachowska, M. | Muchowicz, A. | Golab, J.

54

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

enthalten in: Theranostics | 2022

von Moon, Y. | Shim, M. | Choi, J. | +8

55

Lactobacillus Suppresses Tumorigenesis of Oropharyngeal Cancer via Enhancing Anti-Tumor Immune Response

in: Frontiers in Cell and Developmental Biology | 2022

von Ke-Ke Wang | Ke-Ke Wang | Kai-Yue He | +7

56

Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer

in: Cancers | 2022

von Huijiao Lu | Mengyi Zhu | Lin Qu | +3

57

Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications

in: Antioxidants | 2022

von Ruolan Liu | Liyuan Peng | Li Zhou | +3

58

Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer

in: Bioengineering & Translational Medicine | 2022

von Haiqin Huang | Lanlan Shao | Yan Chen | +4

59

Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy

in: Acta Pharmaceutica Sinica B | 2022

von Yongrong Yao | Huachao Chen | Ninghua Tan

60

Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response

in: Molecular Therapy: Oncolytics | 2022

von Yalei Zhang | Ling Qian | Kun Chen | +5